suzanne sisley

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

Ohio: Researcher Dr. Suzanne Sisley To Discuss Effects of Marijuana on PTSD

SuzanneSisley[ApeksSupercritical].jpg

By Steve Elliott
Hemp News

Renowned PTSD researcher Dr. Suzanne Sisley will be addressing the Ohio House of Representatives Marijuana Task Force and speaking to the media and the Ohio community during a Thursday press conference.

Dr. Sisley, of Scottsdale, Arizona, is a physician in the field of medicinal cannabis and will share her expertise with the Ohio House task force on medical marijuana.

She will address the potential benefits of using cannabis to treat PTSD; in addition, there will be a press conference for media personnel and others to hear Dr. Sisley discuss her work.

The press conference will be at 1 p.m. on Thursday, February 18, at the Ohio Statehouse, Ladies Gallery. Those planning to attend should RSVP to Cid Rhomberg of Apeks Supercritical, a CO2 botanical extraction equipment manufacturer based in Johnstown, Ohio.

The Marijuana Task Force testimony will be at 7 p.m. on Thursday, February 18, at the Ohio Statehouse, Room 313, Finance Conference room.

New York: Tikun Olam Announces Its First U.S. Medical Marijuana Partnership

TikunOlamMedicalMarijuanaGreenhouse[TikumOlam.info]

Tikun Olam® Ltd., the first, largest and foremost government-licensed producer of medical cannabis in Israel, on Thursday announced a joint partnership in New York State with Compassionate Care Center of New YorkTM (CCCNY), a privately held New York-based biopharmaceutical company applying to be a Registered Organization under New York's Compassionate Care Act, and MedReleaf Corp., a privately held federally-licensed producer and distributor of medical-grade cannabis in Canada, which has set the gold standard for the industrial production of medical-grade cannabis in North America.

Founded in 2005, Tikun Olam is the only large-scale industrial producer of medical cannabis in Israel, supplying one third of qualifying Israeli patients with pharmaceutical-grade products. Tikun Olam has the most extensive patient experience treatment database in the field of medical cannabis with over 10,000 patients being monitored for nearly a decade and the data for the treatment of each patient's ailments recorded along with the efficacy of the different strain variations and dosages administered.

It is the only private company to have its proprietary medical strains of specifically-bred cannabis clinically tested on humans and referenced by name in peer-reviewed published articles reporting on the successful trials. In fact, Tikun Olam's strain Erez® was used in the only completed double-blind-placebo clinical trial on humans for Crohn's disease, which resulted in complete remission for 50 percent of the patients in the cannabis group and 10 percent in the controlled group.

New York: Compassionate Care Center Applies For Medical Cannabis License

CCNY - TakeTheShacklesOff.GiveMedicalMarijuanaToThoseWhoNeedIt.NYStateofMMJ

Compassionate Care Center of New York™ (CCCNY™), a biopharmaceutical company applying to become one of five registered organizations authorized in New York State to serve the condition-specific palliative needs of qualifying patients with safe and accessible pharmaceutical-grade therapeutics derived from the cannabis plant, has announced the formation of a leadership team.

The team consists of medical, regulatory and law enforcement experts, including gastroenterologist Dr. Larry I. Good; former executive vice president and vice chairman of CVS Corporation, Jerald Politzer; former New York State prosecutor Richard W. Lerner, Esq.; leading medical cannabis PTSD researcher Dr. Suzanne Sisley; regulatory affairs expert Dr. Bruce Burnett; former chief security officer of the Port Authority of New York and New Jersey, Joseph Dunne; and former NYPD Chief of Department Philip Banks III.

"CCCNY will serve as a vital resource for qualifying patients in New York in need of palliative care," said Dr. Good, CEO of CCCNY. "By assembling a world-class team of cultivators, medical experts and researchers, along with New York State's top two highest ranking police officers to retire in 2014, and the former executive vice president and vice chairman of CVS Corporation, we will be able to provide organic pharmaceutical-grade whole-plant extracts, with consistent cannabinoid profiles, at our Compassionate Care Centers throughout the State -- built to function like pharmacies, but equipped with the most state-of-the-art security available.

Illinois: Medical Cannabis Physicians' Summit Aims To Educate Medical Community

IllinoisMedicalMarijuanaPhysiciansSummitGreenCrossLeaves

The Canna Law Group, in partnership with the Epilepsy Foundation of Greater Chicago, Americans for Safe Access, and the Marijuana Policy Project, is co-hosting the Illinois Medical Cannabis Physicians’ Summit on Friday, June 5, 2015 at the Westin Chicago River North.

The summit will educate licensed medical professionals on current medical cannabis research, state and federal law, and the Illinois Medical Cannabis Pilot Program. “Educating the medical community about medical cannabis treatment options is essential for the long-term success of the program,” said Rep. Lou Lang, prime sponsor of the current medical cannabis law.

The event will feature as its keynote speaker leading cannabis researcher Dr. Donald Abrams, who has conducted multiple FDA-approved studies on the medical benefits of cannabis. Dr. Suzanne Sisley, another clinical researcher on cannabis who studies its benefits for PTSD sufferers, will also speak at the summit.

“Many doctors need to better understand the current research behind medical cannabis,” said Dr. Abrams. “This is a chance to share my own first-hand research experiences at the University of California San Francisco and educate Illinois doctors about how I've applied those experiences in a clinical setting.”

Also speaking is Dr. Leslie Mendoza-Temple, chair of the Illinois Medical Cannabis Advisory Board, who said “This will be an important event for any medical professional who wants to understand the research, law, and administrative processes of a program that will help thousands of patients in Illinois.”

U.S.: Marijuana PTSD Researcher Abruptly Fired From University of Arizona

SuzanneSisleyMarijuanaResearcher

By Steve Elliott
Hemp News

A prominent marijuana researcher who only months ago had received rare federal approval to study the effects of cannabis on patients with post traumatic stress disorder has been abruptly fired by the University of Arizona.

Professor Suzanne A. Sisley's dismissal puts her research at risk, and has caused dismay among medical marijuana advocates, reports Evan Halper at The Los Angeles Times.

Dr. Sisley, a clinical assistant professor of psychiatry, said she was fired after her research created unwanted attention for the university from legislative Republicans who control its funding.

"This is a clear political retaliation for the advocacy and educaiton I have been providing the public and lawmakers," Sisley said. "I pulled all my evaluations and this is not about my job performance."

University officials refused to explain the non-renewal of Sisley's contract, but claimed their motives weren't political.

"The university has received no political pressure to terminate any employee," claimed University of Arizona spokesman Chris Sigurdson, who noted that university supported a 2013 legislative measure permitting such studies.

Dr. Sisley got letters from university officials on Friday, telling her that she will be terminated from her job on September 26. The letters offered no explanation beyond citing guidelines which permit the university to fire its employees.

Syndicate content